Heartflow (NASDAQ:HTFL) CEO Sells $1,928,273.00 in Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 38,900 shares of Heartflow stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $49.57, for a total transaction of $1,928,273.00. Following the sale, the chief executive officer directly owned 283,014 shares in the company, valued at $14,029,003.98. This trade represents a 12.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total value of $194,500.00.
• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The stock was sold at an average price of $46.42, for a total value of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The shares were sold at an average price of $45.00, for a total value of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.
• On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.

Heartflow Stock Down 5.1%

NASDAQ HTFL opened at $48.29 on Friday. The business has a 50 day moving average price of $47.26 and a 200-day moving average price of $35.26. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $54.32. The company has a market cap of $4.20 billion, a price-to-earnings ratio of -26.39 and a beta of 2.73.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The firm had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. Heartflow’s quarterly revenue was up 47.7% on a year-over-year basis. On average, equities research analysts anticipate that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. XXEC Inc. acquired a new stake in shares of Heartflow in the second quarter worth $2,524,764,000. BlackRock Inc. acquired a new position in shares of Heartflow during the 2nd quarter worth approximately $152,502,000. Bamco Inc. NY acquired a new stake in Heartflow in the 2nd quarter valued at $94,625,000. Jupiter Topco LLC acquired a new position in Heartflow during the second quarter worth $70,983,000. Finally, Janus Henderson Group PLC increased its stake in Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after buying an additional 1,315,416 shares in the last quarter.

Analyst Ratings Changes

Several equities analysts recently commented on the company. JPMorgan Chase & Co. boosted their target price on Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Wells Fargo & Company increased their price objective on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Finally, Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $46.25.

Heartflow Company Profile

HeartFlow, Inc is a medical technology company focused on improving the diagnosis and management of coronary artery disease. The company develops software and clinical tools that use artificial intelligence, advanced image analysis and data from coronary computed tomography angiography (CCTA) scans to provide noninvasive assessments of blood flow and potential blockages in the heart.

Its principal product is the HeartFlow Analysis, which creates a personalized, three-dimensional model of a patient’s coronary arteries and can estimate the impact of blockages on blood flow.